Morgan Stanley keeps Underweight on Cipla; target ₹1,218
Cipla shares traded lower on Sept. 4 after Morgan Stanley retained an Underweight rating and set a target price of ₹1,218, the second-lowest among analysts covering the stock.
Shares of Cipla Ltd. were trading in the red on Friday, September 4, after Morgan Stanley retained its Underweight rating on the drugmaker with a target price of ₹1,218, making it the second-lowest target among analysts who track the stock.The brokerage's target implies a downside potential of 12.4…